Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy

doi:10.1017/9781316492376.010

Chapter 10 - Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy

Published online by Cambridge University Press: 20 August 2020

Edited by

Raman Sankar and

John M. Stern: Affiliation:
Geffen School of Medicine at UCLA, Los Angeles, CA
Raman Sankar: Affiliation:
Geffen School of Medicine at UCLA, Los Angeles, CA
Michael Sperling: Affiliation:
Jefferson Hospital for Neurosciences, Philadelphia, PA

Book contents

Get access

Summary

Malformations of cortical development (MCD) are by now well recognized causes of neurodevelopmental disorders and epilepsy [1]. The precise etiological mechanisms, clinical features and course vary as patients present with a wide range of developmental disorders, associated somatic and cortical malformations, and epilepsy. Specific clinical phenotypes can be recognized in a proportion of patients based on common clinical and imaging features. Furthermore, genetic testing allows for specific phenotype–genotype classification. However, as with many genetic disorders, the phenotypic variability is large, presenting a challenge to the diagnosis and clinical management of these patients.

Type: Chapter
Information: Medication-Resistant Epilepsy
Diagnosis and Treatment
, pp. 79 - 86

DOI: https://doi.org/10.1017/9781316492376.010 [Opens in a new window]

Publisher: Cambridge University Press

Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Kuzniecky, RI. Malformations of cortical development and epilepsy, part 1: diagnosis and classification scheme. Rev Neurol Dis 2006;3(4):151–162Google Scholar PubMed

Barkovich, AJ, Guerrini, R, Kuzniecky, RI, Jackson, GD, Dobyns, WB. A developmental and genetic classification for malformations of cortical development: update 2012. Brain 2012;135:1348–1369CrossRef Google Scholar PubMed

Guerrini, R, Dobyns, WB. Malformations of cortical development: clinical features and genetic causes. Lancet Neurol 2014;13:710–726Google Scholar

Bae, BI, Tietjen, I, Atabay, KD, et al. Evolutionarily dynamic alternative splicing of GPR56 regulates regional cerebral cortical patterning. Science 2014;343(6172):764–768Google Scholar

Jamuar, SS, Lam, AT, Kircher, M, et al. Somatic mutations in cerebral cortical malformations. N Engl J Med 2014;371(8):733–743CrossRef Google Scholar PubMed

Lee, JH, Huynh, M, Silhavy, JL, et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012;44:941–945CrossRef Google Scholar PubMed

Marin-Valencia, I, Guerrini, R, Gleeson, JG. Pathogenetic mechanisms of focal cortical dysplasia. Epilepsia 2014;55(7):970–978CrossRef Google Scholar PubMed

Wang, VY, Chang, EF, Barbaro, NM. Focal cortical dysplasia: a review of pathological features, genetics, and surgical outcome. Neurosurg Focus 2006;20(1):E7Google Scholar

Aronica, E., et al. Differential expression patterns of chloride transporters, Na+–K+–2Cl–cotransporter and K+–Cl–cotransporter, in epilepsy-associated malformations of cortical development. Neuroscience 2007;145(1):185–196CrossRef Google Scholar PubMed

Rakhade, SN, Jensen, FE. Epileptogenesis in the immature brain: emerging mechanisms. Nat Rev Neurol 2009;5(7):380–391CrossRef Google Scholar PubMed

André, VM, Wu, N, Yamazaki, I, et al. Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical dysplasia. J Neuropathol Exp Neurol 2007;66:491–504Google Scholar

Crino, PB. Molecular pathogenesis of focal cortical dysplasia and hemimegalencephaly. J Child Neurol 2005;20(4):330–336CrossRef Google Scholar PubMed

Mirzaa, GM, Conway, RL, Gripp, KW, et al. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 2012;158A(2):269–291Google Scholar

Blumcke, I, Thom, M, Aronica, E, et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011;52:158–174CrossRef Google Scholar

Hsu, PP, Kang, SA, Rameseder, J, et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011;332:1317–1322CrossRef Google Scholar PubMed

Zhou, J, Blundell, J, Ogawa, S, et al. Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci 2009;29:1773–1783CrossRef Google Scholar PubMed

Epilepsy Electroclinical Study Group, Ricos, M Hodgson, BL. Pippucci, T, et al. Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsy. Ann Neurol 2016;79(1):120–131CrossRef Google Scholar PubMed

Romaniello, R, Arrigoni, F, Bassi, MT, Borgatti, R. Mutations in a- and b-tubulin encoding genes: implications in brain malformations. Brain Dev 2014;37(3):273–280Google Scholar

Pilz, D, Stoodley, N, Golden, JA. Neuronal migration, cerebral cortical development, and cerebral cortical anomalies. J Neuropathol Exp Neurol 2002;61(1):1–11CrossRef Google Scholar PubMed

Gleeson, JG, Allen, KM, Fox, JW, et al. Doublecortin, a brain-specific gene mutated in human x-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998;92:63–72CrossRef Google Scholar PubMed

Saillour, Y, Carion, N, Quelin, C, et al. LIS1-related isolated lissencephaly: spectrum of mutations and relationships with malformation severity. Arch Neurol 2009;66(8):1007–1015Google Scholar

Morris, EB, 3rd, Parisi, JE, Buchhalter, JR. Histopathologic findings of malformations of cortical development in an epilepsy surgery cohort. Arch Pathol Lab Med 2006;130(8):1163–1168Google Scholar

Kuzniecky, R, Andermann, F, Guerrini, R. Congenital bilateral perisylvian syndrome: study of 31 patients. The CBPS Multicenter Collaborative Study. Lancet 1993;341(8845):608–612Google Scholar

Jansen, AC, Robitaille, Y, Honavar, M, et al. The histopathology of polymicrogyria: a series of 71 brain autopsy studies. Dev Med Child Neurol 2016;58:39–48Google Scholar

Baulac, S, Lenk, GM, Dufresnois, B, et al. Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria. Neurology 2014;82(12):1068-1075CrossRef Google Scholar PubMed

De Ciantis, A, Barkovich, AJ, Cosottini, M, et al. Ultra-high-field MR imaging in polymicrogyria and epilepsy. Am J Neuroradiol 2014;36(2):309-316Google Scholar

Caraballo, RH, Cersósimo, RO, Fortini, PS, et al. Congenital hemiparesis, unilateral polymicrogyria and epilepsy with or without status epilepticus during sleep: a study of 66 patients with long-term follow-up. Epileptic Disord 2013;15(4):417–427CrossRef Google Scholar PubMed

Fox, JW, Lamperti, ED, Ekşioğlu, YZ, et al. Mutations in filamin 1 prevent migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 1998;21(6):1315–1325Google Scholar

Sheen, VL, Topçu, M, Berkovic, S, et al. Autosomal recessive form of periventricular heterotopia. Neurology 2003;60(7):1108–1112CrossRef Google Scholar PubMed

Kielar, M, Tuy, FPD, Bizzotto, S. Mutations in Eml1 lead to ectopic progenitors and neuronal heterotopia in mouse and human. Nat Neurosci 2014;17(7):923-933CrossRef Google Scholar PubMed

Book contents

Chapter 10 - Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy

Summary

Access options

References

Save book to Kindle

Save book to Dropbox

Save book to Google Drive